Discover 3,049 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,049
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Duarte CA, La Jolla CA, Las Vegas NV,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase 1, Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Los Angeles CA, Los Alamitos CA, Lancaster CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07499232
Phase 3, Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Glendale CA, Anaheim CA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT06629779
Phase 3, Recruiting
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
for
Lung Cancer, Lung Metastases
Location: Duarte CA, Aurora CO, Houston TX, Rochester MN,
Sponsor: Vergent Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07499674
Phase 3, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Los Angeles CA, Cerritos CA, Newport Beach CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
for
HER2 Expressing Solid Tumors
Location: Los Angeles CA, Denver CO, Houston TX, Rochester MN,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT07192432
Phase 1, Phase 2, Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
for
Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer,
Location: Los Angeles CA, Glendale CA, Long Beach CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07625644
Phase 3, Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Duarte CA, San Diego CA, Fresno CA, Tuscon AZ,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase 2, Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
for
Solid Tumours
Location: Los Angeles CA, Orange CA, Houston TX, St Louis MO,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT06725758
Phase 1, Phase 2, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device
for
Diabetes Mellitus
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT06965803
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
for
Extensive-stage Small-cell Lung Cancer
Location: Los Angeles CA, Lexington KY, Atlanta GA, Rock Hill SC,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07459634
Phase 2, Recruiting
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
for
Knee Osteoarthritis, Depression
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 50 - 70+
Code: NCT06906939
Early Phase 1, Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Los Angeles CA, Salt Lake City UT, Dallas TX,
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07470853
Phase 1, Recruiting
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
for
Neoplasm Metastasis, Non-Small Cell Lung Cancer
Location: Los Angeles CA, Duarte CA, Orange CA, Sacramento CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT04886804
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Los Alamitos CA, Fullerton CA, Fountain Valley CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
for
Glioblastoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07461948
Phase 3, Recruiting
A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.
for
Periodontitis (Stage 3)
Location: Fullerton CA, La Vista NE, Victoria TX, Spring TX,
Sponsor: McGuire Institute
Sex: All
Age: 30 - 70+
Code: NCT06914596
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Fullerton CA, Vista CA, Encinitas CA, San Diego CA,